Stenocare

0.9

DKK

-7.69 %

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

Less than 1K followers

-7.69%

-30.77%

-40%

-57.94%

-78.16%

-64.14%

-94.17%

-96.63%

-96.32%

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Market cap

18.19M DKK

Turnover

88.7K DKK

Revenue

6.92M

EBIT %

-230.49 %

P/E

-

Dividend yield-%

-

Financial calendar

27/2

2025

Annual report '24

8/5

2025

Interim report Q1'25

21/8

2025

Interim report Q2'25

ShowingAll content types

Press releaseyesterday

STENOCARE A/S: The subscription period in Stenocare's conditional rights issue begins today for the time limited offer of DKK 0,50 per new share

Press release1/3/2025, 10:21 AM

STENOCARE's Innovative ASTRUM 10-10 Product Now Available for Norwegian Patients

Press release12/20/2024, 10:35 AM

Analyst Group: Analyst Group's Comment on STENOCARE’s Announcement of a Conditional Rights Issue of up to DKK 20.2m

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release12/18/2024, 6:00 PM

STENOCARE A/S: Conditional Rights Issue of up to 20.2 mDKK

Regulatory press release12/18/2024, 12:37 PM

Communiqué from extraordinary general meeting in STENOCARE

Press release12/17/2024, 9:31 AM

Analyst Group: Analyst Group Comment on STENOCARE’s Approval for a new Medical Cannabis CBD100 oil

Press release12/17/2024, 7:00 AM

STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil

Press release12/10/2024, 2:38 PM

STENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com

Press release12/2/2024, 10:33 AM

Analyst Group: Analyst Group Comment on that STENOCARE’s Astrum Oil has been Approved for Sales in Norway

Press release12/2/2024, 7:00 AM

STENOCARE - Innovative New ASTRUM Product Officially Approved for Sale in Norway

Press release11/28/2024, 9:14 PM

STENOCARE Celebrates Denmark's Permanent Legalisation of Medical Cannabis

Press release11/27/2024, 1:34 PM

Analyst Group: Analyst Group Comment on STENOCARE Shifting Strategy to Focus on Trading and Exit from Production

Regulatory press release11/26/2024, 4:46 PM

STENOCARE 3.0: Shifting Strategy to Focus on Trading and exit from Production

Regulatory press release11/26/2024, 4:11 PM

Notice to Extraordinary General Meeting in STENOCARE A/S

Press release11/20/2024, 8:28 AM

Analyst Group: Comment on the Impact for Stenocare in Regards to the Danish Health Minister’s Decision to Propose a Permanent Legalization of Medical Cannabis

Press release11/19/2024, 12:09 PM

STENOCARE Welcomes Danish Health Minister's Decision to Permanently Legalise Medical Cannabis for Patients

Press release11/11/2024, 1:56 PM

Analyst Group: Equity Research Report on STENOCARE - Tough Market Conditions Hampers the Growth

Press release11/6/2024, 10:05 AM

Analyst Group: Analyst Group Comment on STENOCARE’s Q3-Report 2024

Regulatory press release11/5/2024, 12:31 PM

STENOCARE: Interim Report Third Quarter 2024

Regulatory press release11/1/2024, 12:31 PM

STENOCARE Change in the Board of Directors

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.